1. Home
  2. FENG vs CING Comparison

FENG vs CING Comparison

Compare FENG & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

HOLD

Current Price

$2.03

Market Cap

32.7M

Sector

Industrials

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.44

Market Cap

26.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FENG
CING
Founded
1998
2012
Country
China
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
26.4M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
FENG
CING
Price
$2.03
$4.44
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
2.5K
122.1K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,947,410.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.17
N/A
52 Week Low
$1.28
$3.20
52 Week High
$3.65
$6.01

Technical Indicators

Market Signals
Indicator
FENG
CING
Relative Strength Index (RSI) 39.94 71.13
Support Level $2.01 $3.75
Resistance Level $2.08 $4.02
Average True Range (ATR) 0.04 0.21
MACD 0.01 0.07
Stochastic Oscillator 13.33 96.30

Price Performance

Historical Comparison
FENG
CING

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: